Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Evaluate the Similarity in Pharmacokinetics and Safety of IBI310 and Ipilimumab（YERVOY）in Adult Healthy Chinese Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation
- Status
- WITHDRAWN
- Phase
- PHASE1
Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neo-adjuvant Nivolumab or Nivolumab With Ipilimumab in Advanced Cutaneous Squamous Cell Carcinoma Prior to Surgery
- Status
- COMPLETED
- Phase
- PHASE2
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC
- Status
- TERMINATED
- Phase
- PHASE1
Surgical Nivolumab And Ipilimumab For Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2